BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
22.90
-1.99 (-8.00%)
Jul 10, 2026, 10:20 AM EDT - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $1.02 billion as of July 10, 2026. Its market cap has increased by 554.27% in one year.
Market Cap
1.02B
Enterprise Value
725.59M
1-Year Change
554.27%
Ranking
Category
Stock Price
$22.90
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $1.02B, an increase of 65.52%. That is a compound annual growth rate of 32.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 1.05B | 121.44% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.49B |
| Perrigo Company | 1.44B |
| Phibro Animal Health | 1.31B |
| Alvotech | 1.18B |
| Collegium Pharmaceutical | 1.16B |
| Cronos Group | 1.04B |
| Eton Pharmaceuticals | 1.02B |
| Evotec SE | 1.01B |